CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2.
about
Role of NADPH oxidase in formation and function of multinucleated giant cellsModulation of CD44 Activity by A6-PeptideInhibition of the plasma membrane Ca2+ pump by CD44 receptor activation of tyrosine kinases increases the action potential afterhyperpolarization in sensory neuronsCellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus.Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.Rac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptidesUpdates of reactive oxygen species in melanoma etiology and progression.Reactive oxygen species are indispensable in ovulationRole of versican, hyaluronan and CD44 in ovarian cancer metastasis.ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.BMP-2 induces versican and hyaluronan that contribute to post-EMT AV cushion cell migration.Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor.Hyaluronan regulation of endothelial barrier function in cancer.Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasUpregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival.An introduction to proteoglycans and their localizationEndocardial-to-mesenchymal transformation and mesenchymal cell colonization at the onset of human cardiac valve developmentMechanical Characterization of a Dynamic and Tunable Methacrylated Hyaluronic Acid Hydrogel.Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer.miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.Comprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.Shedding light on proteolytic cleavage of CD44: the responsible sheddase and functional significance of shedding.Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity.Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?CD44 in hematological neoplasias.Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.Role of hyaluronan and CD44 in reactive oxygen species-induced mucus hypersecretion.Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
P2860
Q24633426-EAA2EF69-CAB5-4AC0-AE3B-3F5B36D38ABEQ28085166-4DB6CBBE-32B2-476F-AFAD-DF2A25C5639EQ28577210-3BBE4F14-E8DD-4293-B645-EE357A389597Q33674704-213B508B-EB57-4EA4-9390-50F0CCDD7825Q33688875-9EA064E2-0F45-42C9-96CA-2A155237E8ADQ33727690-A3928589-BAD2-4CF2-8862-3B0D2DA50555Q33740683-17BAAF7B-7ADA-498F-8707-F5B7A735E1EEQ33766973-B6B72F32-5690-47AC-BA60-BA28A1517714Q34042822-D5C3C1D3-4377-4E17-84AC-EFE96EDC56DCQ34044908-45B15021-78D9-4800-911A-3B62A5C91B34Q34074465-713ACE90-4763-4364-A796-C4DFD0583FA1Q34216061-48F90A7D-5786-429F-AF98-2B7A6D1568EEQ34285372-53E7FE6D-04BD-4D37-BC63-3E5399003772Q34403921-4D906587-11F5-4C8F-B5E0-7D0281778199Q34534312-545604DA-5320-4C01-B2DF-0152A36F00BAQ34874835-32121780-9682-47F4-A95E-13DE969E5DE1Q34981642-FCC4BD18-F93A-4126-AD2A-F622A71A1D5DQ35023249-B1E61204-E744-4DF6-8143-CB2698BD26B1Q35440662-EDCA2383-9B6C-4E86-9A31-0CB09494F976Q35528026-C65487C6-A4FE-4C7D-BF46-A236F822F3EBQ35751329-AEE9F7B0-1270-47CB-9A64-B93DCA9E61CDQ35845352-D1E89895-EC68-4758-ACFB-FB017F969A4CQ36334849-BE394D8A-69A7-4269-82B8-38646B1B73C5Q36481630-ABBED675-F826-42E1-888D-A2479E7A2DA3Q36597438-4EF046C6-4B6D-470C-A962-4DEFD8DF52A1Q36833080-689EC281-320A-425F-A5E5-50B1FABB6EF8Q36962804-E246F20D-BADB-499E-958D-E0BC1385874AQ36962950-B5EF4CD7-B6A4-4DCF-AA57-5C0CC26F4893Q37093818-AF95580D-9668-449B-843A-82D789CCE146Q37381798-43021AC0-7401-49AB-ABAB-F6BAB44FCCC5Q37461694-4442EF46-8B69-4C16-BDD0-404F1BDCFF90Q37665446-DFF1023B-6738-45AB-AAB7-AE2022780C2CQ37666618-B819CF19-295B-493A-AAC9-150FA851FF09Q37831812-9CB89C95-5D9C-4238-90AE-576EC8B393E4Q38845190-3C9A600E-59B8-4E43-8D50-7FC0E9E8994BQ38939358-23717E8F-D061-4889-99C3-D3694ECC54EFQ39595039-6C1AA42E-EA4F-434B-BE19-AB2C66D1DAE2Q39723976-E91DD0A9-4F9D-4CE3-80AA-28038B5E7494Q41770109-A1E425DB-5281-4777-BB99-CB247C997B74Q42347025-4D65B9DB-3A77-4EAF-8938-E331A8149405
P2860
CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@en
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@nl
type
label
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@en
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@nl
prefLabel
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@en
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@nl
P2093
P2860
P356
P1476
CD44-epidermal growth factor r ...... al adhesion kinase, and MMP-2.
@en
P2093
Dooil Jeoung
Hansoo Lee
Jongseon Choe
Young-Myeong Kim
Youngmi Kim
Yun-Sil Lee
P2860
P304
22513-22528
P356
10.1074/JBC.M708319200
P407
P577
2008-06-24T00:00:00Z